QQ客服 官方微博 反馈留言

	A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer.
	Ledan Wang; Wangqi Du; Shanli Zhu; Pengfei Jiang; Lifang Zhang
刊名	Applied microbiology and biotechnology
	2019
关键词	Affibody Cervical cancer treatment E7 oncogene High-risk papillomavirus In vivo distribution Surface plasmon resonance Targeting
ISSN号	1432-0614
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4742812
专题	湖南大学
作者单位	1.Department of Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China. Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, 325035, China. Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, 325035, China. wzfeyzlf@12 2.com.
推荐引用方式 GB/T 7714	Ledan Wang,Wangqi Du,Shanli Zhu,et al. A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer.[J]. Applied microbiology and biotechnology,2019.
APA	Ledan Wang,Wangqi Du,Shanli Zhu,Pengfei Jiang,&Lifang Zhang.(2019).A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer..Applied microbiology and biotechnology.
MLA	Ledan Wang,et al."A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer.".Applied microbiology and biotechnology (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。